News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
619,822 Results
Type
Article (53696)
Company Profile (126)
Press Release (565982)
Multimedia
Podcasts (216)
Webinars (33)
Section
Business (182584)
Career Advice (2612)
Deals (30282)
Drug Delivery (229)
Drug Development (73106)
Employer Resources (167)
FDA (16638)
Job Trends (13113)
News (285558)
Policy (31027)
Tag
2025 Best Places to Work (14)
2026 Best Places to Work (21)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (4)
2027 Genetown Standard (6)
2027 Pharm Country Standard (4)
40 Under 40 (4)
Academia (2508)
Academic (1)
Accelerated approval (77)
ADA (54)
Adcomms (44)
Allergies (214)
Alliances (39759)
ALS (272)
Alzheimer's disease (2042)
Antibody-drug conjugate (ADC) (721)
Approvals (17179)
Artificial intelligence (931)
ASCO (331)
Autoimmune disease (502)
Automation (67)
Bankruptcy (339)
Belgium (45)
Best Places to Work (9783)
BIO (78)
Biologics (109)
BIOSECURE Act (23)
Biosimilars (285)
BioSpace Insights (183)
Biotechnology (80)
Bispecific (57)
Bladder cancer (244)
Brain cancer (91)
Breast cancer (880)
Cancer (7423)
Cardiovascular disease (641)
Career advice (2241)
Career pathing (62)
CAR-T (401)
CDC (82)
CDMO (216)
Celiac Disease (5)
Cell-line development (2)
Cell therapy (1120)
Cervical cancer (65)
Clinical research (65925)
Collaboration (2452)
Commercialization (62)
Company closure (9)
Compensation (1872)
Complete response letters (127)
COVID-19 (2860)
CRISPR (145)
CRO (7)
C-suite (1540)
Cystic fibrosis (170)
Data (10470)
Decentralized trials (4)
Denatured (61)
Depression (216)
Dermatology (194)
Diabetes (770)
Diagnostics (6335)
Digital health (65)
Diversity (10)
Diversity, equity & inclusion (43)
Drug discovery (447)
Drug pricing (249)
Drug shortages (34)
Duchenne muscular dystrophy (375)
Earnings (69014)
Editorial (85)
Employer branding (21)
Employer resources (154)
ESMO (404)
Events (95877)
Executive appointments (1226)
Eye disease (26)
FDA (21564)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (5)
Friedreich's ataxia (28)
Frontotemporal dementia (38)
Funding (2037)
Gene editing (296)
Generative AI (85)
Gene therapy (898)
GLP-1 (1328)
Government (4444)
Grass and pollen (8)
Guidances (428)
Healthcare (16085)
Hematology (216)
HIV (117)
Huntington's disease (91)
Idiopathic pulmonary fibrosis (15)
IgA nephropathy (153)
Immunology and inflammation (423)
Immuno-oncology (146)
Indications (278)
Infectious disease (3272)
Inflammatory bowel disease (258)
Inflation Reduction Act (14)
Influenza (148)
Intellectual property (361)
Interviews (492)
IPO (14807)
IRA (58)
Job creations (3507)
Job search strategy (1808)
JPM (71)
Kidney cancer (31)
Kidney disease (170)
Labor market (136)
Layoffs (699)
Leadership (68)
Legal (7374)
Licensing (119)
Liver cancer (115)
Longevity (46)
Lung cancer (1025)
Lung diease (26)
Lymphoma (547)
Machine learning (70)
Management (59)
Manufacturing (1447)
Marketing (39)
MASH (250)
Medical affairs (5)
Medical device (12282)
Medtech (12561)
Mergers & acquisitions (16882)
Metabolic disorders (2026)
Middle East (2)
mRNA (319)
Multiple sclerosis (232)
Multispecific (7)
NASH (23)
Netherlands (39)
Neurodegenerative disease (586)
Neuropsychiatric disorders (149)
Neuroscience (4073)
Neurotech (4)
NextGen: Class of 2026 (5341)
Non-profit (3516)
Now hiring (79)
Obesity (984)
Opinion (383)
Ovarian cancer (267)
Pain (313)
Pancreatic cancer (435)
Parkinson's disease (460)
Partnered (40)
Patents (753)
Patient advocacy (4)
Patient recruitment (912)
Patient selection (109)
Peanut (73)
People (50536)
Peptides (40)
Pharmaceutical (33)
Pharmacy benefit managers (41)
Phase 1 (19927)
Phase 2 (28657)
Phase 3 (22994)
Pipeline (13794)
Policy (422)
Postmarket research (2367)
Preclinical (8088)
Press Release (61)
Prostate cancer (398)
Psychedelics (99)
Radioligand (3)
Radiopharmaceuticals (385)
Rare diseases (1528)
Real estate (4946)
Recruiting (72)
Regenerative medicine (34)
Regulatory (26574)
Reports (67)
Research institute (2324)
Resumes & cover letters (432)
Rett syndrome (59)
RNA editing (34)
RSV (95)
Saudi Arabia (1)
Schizophrenia (221)
Series A (359)
Series B (258)
Service/supplier (10)
Sickle cell disease (141)
Special edition (37)
Spinal muscular atrophy (174)
Sponsored (59)
Startups (3255)
State (1)
Stem cells (7)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (154)
Switzerland (24)
Tariffs (108)
Tax incentives (2)
The Weekly (153)
Vaccines (1367)
Venture capital (182)
Weight loss (663)
Wet AMD (7)
Women's health (167)
Women in leadership (2)
Worklife (28)
Date
Today (152)
Last 7 days (814)
Last 30 days (3705)
Last 365 days (30322)
2026 (27517)
2025 (29318)
2024 (32641)
2023 (36565)
2022 (47088)
2021 (50539)
2020 (47426)
2019 (38320)
2018 (29152)
2017 (29491)
2016 (27804)
2015 (30543)
2014 (25491)
2013 (21930)
2012 (20946)
2011 (21463)
2010 (19340)
Location
Africa (774)
Alabama (91)
Alaska (6)
Arizona (369)
Arkansas (14)
Asia (37108)
Australia (6421)
California (15900)
Canada (3811)
China (1776)
Colorado (643)
Connecticut (704)
Delaware (501)
Europe (90560)
Florida (2439)
Georgia (490)
Hawaii (5)
Idaho (45)
Illinois (1229)
India (124)
Indiana (633)
Iowa (34)
Japan (732)
Kansas (130)
Kentucky (58)
Louisiana (63)
Maine (88)
Maryland (1884)
Massachusetts (11452)
Michigan (346)
Minnesota (812)
Mississippi (6)
Missouri (172)
Montana (18)
Nebraska (26)
Nevada (200)
New Hampshire (77)
New Jersey (4214)
New Mexico (23)
New York (4064)
North Carolina (1977)
North Dakota (12)
Northern California (8300)
Ohio (453)
Oklahoma (27)
Oregon (42)
Pennsylvania (2934)
Puerto Rico (30)
Rhode Island (40)
South America (1142)
South Carolina (98)
South Dakota (2)
Southern California (6350)
Tennessee (248)
Texas (2550)
United States (55087)
Utah (398)
Vermont (2)
Virginia (392)
Washington D.C. (76)
Washington State (1209)
West Virginia (4)
Wisconsin (168)
Wyoming (4)
619,822 Results for "cinfa biotech s l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Biotech’s boardroom gains for women fail to translate to CEO roles
Women held 29% of biotech board seats in fiscal year 2025 but just 8.8% of CEO roles, highlighting uneven progress across industry leadership spots.
November 17, 2026
·
1 min read
·
Gabrielle Masson
China
Without US action on China’s innovation blitz, biotech leaders see a Rust Belt future
Policy uncertainty is hampering the growth of U.S. biotech as China rises thanks to carefully planned investment in the industry, experts said during a
BioSpace
webinar.
November 11, 2026
·
5 min read
·
Annalee Armstrong
Venture capital
Alphabet’s GV is one of biotech’s most influential corporate investors
The corporate investor arms of Eli Lilly, Sanofi and Pfizer have participated in billions worth of venture capital rounds, but GV is the industry’s biggest spender.
October 27, 2026
·
2 min read
·
Annalee Armstrong
IPO
Biotech IPOs raise $7.5B as sector’s performance rally flattens
While biopharma financing exit activity has remained strong through the third quarter, public-market performance for the same period was muted, with most of the yearly gains for the U.S. biotech-specific index largely driven by the first half of 2026.
October 26, 2026
·
1 min read
·
Gabrielle Masson
IPO
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
Two RNA biotechs, ADARx Pharmaceuticals and City Therapeutics, are taking advantage of the IPO frenzy, which has led to a total of 27 newly public biotechs so far this year.
September 25, 2026
·
2 min read
·
Gabrielle Masson
China
China’s licensing deals soar as US biotechs enjoy a bumper M&A year
China may be taking the majority of licensing deals this year but those transactions don’t tell the whole story, according to Locust Walk, which points to the spike in M&A among U.S. biotechs as leveling the playing field.
October 21, 2026
·
3 min read
·
Annalee Armstrong
40 Under 40
How a Ms. Frizzle-esque librarian helped Flagship’s Louisa Helms find biotech
BioSpace
40 Under 40 honoree Louisa Helms is a lot of things—athlete, scientist, entrepreneur and likely future biotech executive. Just don’t ask her to pick up any pipettes.
November 4, 2026
·
3 min read
·
Annalee Armstrong
China
China’s surging biotech sector represents both competition and lifeline for the US
As Chinese companies push beyond “me-too” drugs and the country lays out a new five-year plan targeting a $522 billion–strong biotech industry by 2030, experts say more predictable funding and regulation could help the U.S. maintain its edge.
September 23, 2026
·
8 min read
·
Shawna Williams
Deals
Lilly puts $1.1B on the line for Hong Kong biotech’s AI drug delivery platform
METiS TechBio’s AiLNP platform uses machine learning models to develop lipid nanoparticles with potentially better tissue specificity that could enhance a drug’s therapeutic performance.
October 20, 2026
·
1 min read
·
Tristan Manalac
IPO
2026 IPO stock tracker: How newly public biotechs are performing
BioSpace
is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.
November 11, 2026
·
1 min read
·
Gabrielle Masson
1 of 61,983
Next